Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125289961 | 12528996 | 1 | I | 20151110 | 20151113 | 20160705 | 20160705 | PER | US-PFIZER INC-3082437 | PFIZER | 42.00 | YR | M | Y | 0.00000 | 20160705 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125289961 | 12528996 | 1 | PS | LIDOCAINE HCL | LIDOCAINE HYDROCHLORIDE | 1 | Intramuscular | UNK | U | 43042 | 88299 | SOLUTION FOR INJECTION | |||||||
| 125289961 | 12528996 | 2 | C | CEFTRIAXONE. | CEFTRIAXONE | 1 | Intramuscular | 250 MG, UNK | 0 | 250 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125289961 | 12528996 | 1 | Sexually transmitted disease |
| 125289961 | 12528996 | 2 | Sexually transmitted disease |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125289961 | 12528996 | No adverse event | |
| 125289961 | 12528996 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125289961 | 12528996 | 1 | 20151110 | 0 | ||
| 125289961 | 12528996 | 2 | 20151110 | 0 |